This announcement is a separate document:
加科思-B：自願公告加科思宣佈其Pan-KRAS抑制劑JAB-23E73新藥臨床實驗申請(IND)獲美國FDA批准
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED INVESTIGATIONAL NEW DRUG (IND) APPROVAL FROM THE U.S. FDA FOR PAN-KRAS INHIBITOR JAB-23E73
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.